Dyne Therapeutics
102 hedge funds and large institutions have $573M invested in Dyne Therapeutics in 2022 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 33 increasing their positions, 27 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13% more funds holding
Funds holding: 90 → 102 (+12)
2.83% less ownership
Funds ownership: 90.39% → 87.56% (-2.8%)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
102
Holding in Top 10
3
Calls
$517K
Puts
$10K
Top Buyers
| 1 | +$29.1M | |
| 2 | +$5.99M | |
| 3 | +$4.39M | |
| 4 |
Goldman Sachs
New York
|
+$4.21M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$2.81M |
Top Sellers
| 1 | -$19.3M | |
| 2 | -$9.4M | |
| 3 | -$7.78M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$4.58M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$4.01M |